Total Net Assets: Microbot Medical (MBOT)

MBOT (microbotmedical.com) - company brandmark

A retrospective of Microbot Medical Inc. (MBOT) share prices helps assess the business's resilience to geopolitical risks and raw material logistics disruptions. The current indicator stands at 0.07. Investors are betting on the company's progressive image in the field of microrobotics, while Microbot Medical Inc. (MBOT) relies on the development of the Liberty portable disposable system, which enables remote complex vascular interventions.

MBOT Microbot Medical Book Capitalization (07/04/2022 - 10/27/2026)

Microbot Medical (MBOT) - metric breakdowns and financial figures

- price and consensus price forecast:
Market Price Microbot Medical, Inc|MBOT - Consensus Target
- market capitalization data:
Market Value Microbot Medical, Inc.|MBOT - Total Company Value
- book capitalization data:
Accounting Value per Share Microbot Medical|MBOT - Book Capitalization|Market-to-Book Ratio microbotmedical.com|MBOT - Company Total Assets
- debt and liquidity data:
Debt to Equity Ratio Microbot Medical Inc.|MBOT - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Microbot Medical, Inc.|MBOT - Company Aggregate Debts|Debt to Book Value Microbot Medical, Inc.
Fundamental valuation:MBOT - Microbot Medical, Inc
Mass-produced product of Microbot Medical Inc

Book value capitalization determines the actual volume of net assets per unit of investment at the close of the session. This metric measures the intrinsic value of the business, separating market speculation from actual capital. Analyzing the book value of equity allows for an assessment of the issuer's financial stability. For Microbot Medical Inc. (MBOT), this indicator is critical, as high R&D costs deplete resources. The anticipation of FDA approval makes the fundamental support on the chart a key safeguard against excessive volatility.

Competitor analysis for Microbot Medical Inc.

Intuitive Corp (ISRG) - Total Stockholders' Equity|DHR - Company Net Assets|BDX (bd.com) - Total Net Assets|Company Book Value STE|Company Net Assets West Pharma|Baxter Corp - Book Capitalization|Total Stockholders' Equity Masimo Inc. (MASI)|STVN - Book Capitalization|Accounting Capitalization teleflex.com TFX|Book Capitalization MMSI (Merit Medical)|NVST - Book Valuation of Business|ICUI (ICU Medical Corp) - Book Capitalization|Sirona Dental Systems (XRAY) - Company Net Assets|LMAT (LeMaitre Vascular, Inc.) - Book Capitalization|Book Capitalization ATRC|Company Book Value STAAR Surgical (STAA)|Company Book Value Chromadex Corp NAGE|Company Net Assets ZimVie Dental|Accounting Value of Company AngioDynamics Inc. ANGO|Book Capitalization CERS (Cerus Corporation)|TKNO: Book Valuation of Business|Company Book Value Monogram Orthopedics|STSS (Sharps Technology) - Accounting Capitalization|INFU: Company Book Value|Book Valuation of Business Utah Med (UTMD)|Company Net Assets KORU Medical Systems|Total Net Assets NYXH (nyxoah.com)|Company Book Value Pro-Dex|ZTEK - Accounting Value of Company|Elutia Corp - Company Net Assets|MLSS: Book Capitalization|NXGL (NEXGEL, Inc.) - Company Book Value|Retractable Technologies, Inc. (RVP) - Company Net Assets|Book Capitalization HBIO (Harvard Bioscience, Inc.)|Total Stockholders' Equity FEMY|Company Book Value MeihuaMed MHUA|Accounting Capitalization predictive-oncology.com POAI|Company Net Assets Callan JMB (CJMB)|atrioncorp.com - Total Net Assets|Company Book Value NURO (NeuroMetrix)